You are here

  • Home
  • Archive
  • Volume 77, Issue 10
  • PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort study

Citation Tools

Article menu
Original research
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Miglietta F, Carraro V, Amato O, et al
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort study
Journal of Clinical Pathology 2024;77:690-696.